Please assess the completion status of the following clinical trial:

Trial Title: EUS FNB Versus FNA With On-Site Cytopathology in Solid Pancreatic Masses

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient ≥ 18 years of age referred for EUS-guided biopsy for pancreatic mass lesions~Exclusion Criteria:~* Refusal to consent form~* Uncorrectable coagulopathy (INR \> 1.5)~* Uncorrectable thrombocytopenia (platelet \< 50,000)~* Uncooperative patients~* Pregnant women (women of childbearing age will undergo urine pregnancy testing, which is routine for all endoscopic procedures)~* Medically unstable for sedation~* Entirely cystic lesions~* Lesions inaccessible to EUS

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- EUS-FNA with ROSE (Type: ACTIVE_COMPARATOR): EUS/FNA with ROSE will be performed using standard techniques via 22-g FNA needle (Cook Medical EchoTip Ultra or Boston Scientific Expect or Medtronic Beacon). Lesions will be identified using EUS and punctured with the FNA needle (10-15 back and forth movements per needle pass, fanning as appropriate). After the lesion is punctured, the stylet will be removed and 10cc suction will be applied. FNA specimens will be processed for ROSE using standard techniques with bedside smear slide evaluation and liquid-based cytology and cell-block preparation.
- EUS-FNB without ROSE (Type: ACTIVE_COMPARATOR): EUS/FNB without ROSE will be performed using similar techniques for tissue acquisition as FNA using 22-g FNB needle (Medtronic SharkCore or Boston Scientific Acquire). Lesions will be identified using EUS and punctured with the 22-g FNB needle (10-15 back and forth movements per needle pass, fanning as appropriate). After the lesion is punctured, the stylet will be removed and 10cc suction will be applied. FNB samples will be placed directly into formalin containers and sent to be processed by surgical pathology.

Based on this trial design, predict the completion outcome and termination type (if applicable).